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Introduction
Surgical spine research is a growing field involving both
surgeons and scientists. There are many surgeons who look
to high quality research to improve their quality of care.
Although scientists in the field of the spine may also have
other scientific motives, most would agree that they are
also driven by similar aims. On the one hand, spine sur-
geons are most intimately involved in the care of these
patients and have the broadest surgical and clinical
knowledge pertaining to spine ailments. However, most do
not have the time, knowledge or training to conduct labo-
ratory-based spine research. The situation is reversed for
spine scientists, who in some cases have little contact with
clinicians and little understanding of clinical demands.
Thus, scientists may provide the innovative key but have
less understanding of the problem, while surgeons are
constantly faced by the problems, but are frustrated by lack
of sufficient ‘‘tools’’. Both professions require extensive
educational training and have extensive time demands. The
obvious solution is that they should combine forces to more
comprehensively understand spine ailments and to develop
surgical/medical methods to better care for patients from
the bench to the bedside. This was in fact one of the
principles on which this journal was founded [1]. As it was
back then, it remains today that spine surgery needs help
from other disciplines to arrive at better solutions.
In the modern scientific era, projects are complex
involving laboratories, experimental research groups and
clinical partners. Although surgeons often have experiences
during their training with clinical trials supported by indus-
try, collaboration with laboratory-based scientists requires a
different attitude as well as activity. In clinical trials, sur-
geons often are presented with a finished design with well-
determined aims. However, in laboratory-based projects,
surgeons must be active partners with specific and relevant
comments from the planning to interpretation of the results.
Indeed, this type of intense and varied collaboration provides
an opportunity to form a reliable and clinically relevant study
design, but at the same time it is a difficult challenge for both
surgeons and scientists. All partners should be flexible and
open to each other’s questions and it is essential that par-
ticipants learn from each other, with regard to both knowl-
edge and language. These comments are true for clinicians in
general, but it is even more so for surgeons because often the
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interest or the affinity for (basic) science is not encouraged
during specialization. This has been well recognized, and
calls for research training of surgeons or orthopaedists have
already been heard [2, 9]. In addition, such studies may help
surgeons to surpass the scepticism on ‘‘unfocused’’ basic
research aiming at understanding fundamental mechanisms
of tissue structure and function, not immediately translatable
into new treatment regimes, as the outcome of these research
efforts have very often provided major advancements for the
benefit of patients. To help encourage this well-needed col-
laboration, based on our experiences in numerous interna-
tional studies, we present some contributing possibilities
where spine surgeons can become active partners in scien-
tific research.
Basic research fields in spine surgery
To make a successful partnership between clinicians and
scientists, it is important to realize that there are several
varied scientific fields in spine research, each with their own
knowledge base and language. Molecular biology studies
provide data on special biochemical pathways within the
cell. Altered metabolism or other cellular mechanisms can
also be demonstrated in different cell/tissue/organ cultures
by in vitro assays. In many such studies, these are often
sourced from animals. However, as we are interested in the
human condition, more and more studies are, quite rightly,
being conducted with human tissue samples, mostly col-
lected during spine surgery. Accordingly, surgeons must be
encouraged to provide tissue samples, even within the
framework of a busy clinical practice.
With the development of biotechnology, population
genomic studies have become quite common. As spine sur-
geons are faced with more and more disorders, which have an
apparent significant heritable component, genetic investi-
gations have an increasing role in spine research. There are
two major types of genetic studies: genome-wide association
studies (GWAS) and candidate polymorphism association
studies. In the former, allele variants of genetic markers
covering the whole genome are compared between case and
control groups. In the latter, candidate gene polymorphisms
are selected based on an already demonstrated pathogenic
mechanism of the investigated disorder. Genetic studies
often require a large population size and well-defined clinical
phenotypes. Surgeons are critical to defining the phenotypes.
Another basic research area is biomechanics in which
studies are often performed ex vivo and in silico. As the
biomechanical role of the spine is important for its func-
tion, measurements of (1) physical parameters of vertebrae,
(2) soft tissues and (3) spinal muscles can provide signif-
icant insight into the clinical condition. The most recently
developed computational models are able to simulate the
biomechanical conditions of the spine, resulting in the
possibility of carrying out not only biomechanical but also
mechanobiological studies in silico. Such models are often
built on human in vivo data collected in the clinic.
The role of spine surgeons in different phases
of investigation
During preparation of the study design, the spine surgeon
should have a significant role to ensure that the main goal of
the project is clinically relevant. Discussions with scientists
can help to reject ideas, which are beyond technical feasi-
bility. Scientists are usually best at structuring the problem
into specific questions and describing possible methods to
provide answers. Documentation and structural organization
of the collaboration are crucial from the beginning. Although
the scientist often works out the details of the study design,
clinicians can add practical input, especially in ethical, tech-
nical and clinical issues concerning the experimental process
preformed in a hospital (e.g. method of patient recruitment,
definition of exclusion criteria, surgical techniques and pos-
sibilities, ethical approvals, etc.). Indeed, the performance of
the methodological steps in theory and practice is often not
the same. The appropriate implementation of a study design
requires a precise step-by-step protocol created by scientists
with respect to the surgeons’ comments. When the protocol is
ready, a pilot or a preliminary study could be useful to work
out the kinks. Enrollment and informing patients is also a very
important role of the surgeon. S/he must incorporate this
activity into the research schedule and keep in mind the
specific inclusion and exclusion criteria. To get correct sam-
ples for effective processing, s/he should be familiar with the
laboratory methods and get continuous feedback from the
scientists about the samples. Once the data are produced and
analysed, the scientific interpretation of results can be per-
formed well by scientists, but surgeons can more clearly
‘‘translate’’ these results for their medical colleagues and
patients as well. It is especially imperative when preparing the
publication, so that the results of more basic science studies
are transferred into clinical practice.
An example
Most surgeons would insist, if asked, that they do have
enquiring minds and are better than mere surgical techni-
cians. However, it is not always straightforward how they
can transform this into effective research and here is an
anecdotal example from one of the authors of this editorial.
As a young orthopaedic surgeon in South Africa, SE
observed obvious major differences in the clinical patterns
of disease between black and white patients: there was
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almost no spinal claudication and spinal stenosis in the
elderly black patients and sciatica from lumbar disc pro-
lapse was almost unheard of. It was impossible not to be
fascinated by the possible genetic, biochemical and phys-
iological origins of these diseases in one group knowing
that they were nearly absent in another.
Although there was little contribution to the genetics that
he could make, perceiving that most spinal problems in his
domain began with some loss of integrity of the interverte-
bral disc led SE to the notion that he should keep the bits of
disc and facet joints that he was removing from discectomy
patients and stenosis patients, respectively. He took these to
his very patient pathologist. Soon, it became evident that
dehydration, chondrocyte loss and loss of staining was
characteristic of the excised disc fragments, and the facet
joints demonstrated chondrocyte clustering and cartilage
loss in what he was to call ‘‘chondromalacia facetae’’,
indistinguishable from osteoarthritis in any synovial joint. In
a very busy clinical life, he never got round to publishing
anything on the disc, but he did publish on the facet joints [3].
He soon realized that biochemistry of the disc was going
to be necessary to explain the histology. It would be nec-
essary to compare pathological with ‘‘normal’’. He got
linked into the kidney and liver transplant programme and
achieved consent from the families of young organ donors
to allow him to harvest fresh lumbar discs. A colleague
biochemist revealed the marked loss of water in the sur-
gical disc specimens, which he provided, compared to the
harvested young organ donor discs. They published in 1981
[6]: probably not the only publication of its kind in relation
to disc degeneration but, at the time, something of a rev-
elation. How could any surgeon not be fascinated by that?
The findings may not lead to some wonderful surgical cure
or prevention in the near future, but they may do even
better and lead to some non-surgical management in the
medium- to long-term future.
By 1985, SE was living and practising in Oswestry, UK,
and linked in with a resident scientist there, who became his
research partner, a gift of some remarkable circumstances.
They have worked together for 26 years on the disc and its
degeneration. This has helped improve the understanding of
how the disc degenerates [4, 7, 8]. Stimulating an attempt to
develop a permanent and effective treatment, there followed
a quest for a biological approach [5]. Such work has helped
us to realize that a universal silver bullet for discogenic back
pain will be elusive and that cell therapy for disc regenera-
tion is extremely challenging in a degenerate disc where the
tenuous nutrient supply of the disc is often further compro-
mised. This has resulted in a general refocusing of efforts by
many others in spine research towards alternative faster
potential mechanical solutions such as injectable gels. The
many years of surgeon–scientist collaboration has allowed
important conclusions to be achieved and directions for
potential solutions to be identified, which would not have
been possible without this collaboration.
Concluding remarks
The increasing significance of laboratory science in clinical
research is evident in many journals such as the European
Spine Journal. Journals, editors and their referees should
celebrate and support these collaborations. Spine societies,
both large and small, have a critical role not only as a
showcase for such collaborative science, but also as a
forum where such collaborations can be encouraged, set up
and even funded. Funding agencies should look to these
collaborations as the way forward in this area of difficult
research. Surgeons and scientists are both faced with this
challenge: What better way than to develop a rewarding
collaboration with a scientist? It can be an excellent chance
to develop organizing, creative and innovative skills that
are useful for being not only an investigator, but also a
better surgeon. In this way, more significant advances may
result from laboratory-based research for the benefit of
both and especially for spine patients.
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